Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer

Gastric cancer (GC) is the fourth most common cause of cancer-associated death. Based on the age at diagnosis, GC is divided into early-onset GC (EOGC; ≤45 years) and conventional GC (CGC; >45 years). Mutations in the cell cycle checkpoint kinase 2 (CHEK2) and TP53 genes are associated with sever...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Machlowska, Julita, Kapusta, Przemysław, Szlendak, Małgorzata, Bogdali, Anna, Morsink, Folkert, Wołkow, Paweł, Maciejewski, Ryszard, Offerhaus, G. Johan A., Sitarz, Robert
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2021
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7967923/
https://ncbi.nlm.nih.gov/pubmed/33747205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12609
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky